Ausgabe 2/2005
Inhalt (14 Artikel)
Ejaculatory disorders: epidemiology and current approaches to definition, classification and subtyping
Emmanuele A. Jannini, Andrea Lenzi
Retarded ejaculation in men: an overview of psychological and neurobiological insights
Marcel D. Waldinger, Dave H. Schweitzer
Psychological treatment strategies for rapid ejaculation: rationale, practical aspects, and outcome
Stanley E. Althof
Cognitive and partner-related factors in rapid ejaculation: Differences between dysfunctional and functional men.
U. Hartmann, M. Schedlowski, T. H. C. Krüger
Lifelong premature ejaculation: definition, serotonergic neurotransmission and drug treatment
Marcel D. Waldinger
Spinal cord control of ejaculation
Julien Allard, William A. Truitt, Kevin E. McKenna, Lique M. Coolen
Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans
Tillmann H. C. Krüger, Uwe Hartmann, Manfred Schedlowski
Long-term efficacy and safety of a combination of sabal and urtica extract for lower urinary tract symptoms—a placebo-controlled, double-blind, multicenter trial
N. Lopatkin, A. Sivkov, C. Walther, S. Schläfke, A. Medvedev, J. Avdeichuk, G. Golubev, K. Melnik, N. Elenberger, U. Engelmann
Piboserod (SB 207266), a selective 5-HT4 receptor antagonist, reduces serotonin potentiation of neurally-mediated contractile responses of human detrusor muscle
B. Darblade, D. Behr-Roussel, D. Gorny, T. Lebret, G. Benoit, J.-P. Hieble, D. Brooks, L. Alexandre, F. Giuliano